# Dexamethasone for Cerebral Toxoplasmosis

> **NCT04341155** · PHASE2 · RECRUITING · sponsor: **Universitas Padjadjaran** · enrollment: 138 (estimated)

## Conditions studied

- Toxoplasmosis, Cerebral

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04341155
- **Lead sponsor:** Universitas Padjadjaran
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-16
- **Primary completion:** 2025-04
- **Final completion:** 2025-07
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341155, "Dexamethasone for Cerebral Toxoplasmosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04341155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*